Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $12.8250 (3.43%) ($12.8250 - $12.8250) on Thu. Aug. 5, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.2% (three month average) | RSI | 45 | Latest Price | $12.8250(3.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.3% a day on average for past five trading days. | Weekly Trend | ATRA declines -1.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) ARKG(46%) ARKK(45%) IBB(45%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.6% in a week (0% probabilities). VIXM(-37%) VXX(-27%) UNG(-12%) TLT(-10%) UUP(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.6% (StdDev 3.2%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $4.64(-63.82%) | Resistance Level | $13.1 | 5 Day Moving Average | $12.7(0.98%) | 10 Day Moving Average | $12.77(0.43%) | 20 Day Moving Average | $13.1(-2.1%) | To recent high | -22.6% | To recent low | 3.4% | Market Cap | $953m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |